|    about us    | |    FAQs    | |    my account    | |    terms and conditions    | |    privacy policy    |


Add to Google

Add to My AOL

Subscribe in NewsGator Online

Add Charantea USA Diabetic Updates to Newsburst from CNET News.com

Subscribe in Rojo

Subscribe in FeedLounge

Add to netvibes

Subscribe in Bloglines

Archive for Reviews

Momordica charantia Linn. (Family: Cucurbitaceae)

by William D. Torres
I. Introduction Plants have been used for the treatment of diseases throughout the world since the beginning of the civilization. Among…

Read the rest of this entry »

Comments

Clinical Trial in Patients with Diabetes Mellitus of an Insulin-Like Compound from Plant Source

1977 Upsala J. Med Sci. Vol.82, pp.39-41

by V. S. Baldwa, C. M. Bhandari, A. Pangaria, R. K. Goyal A crude extract obtained frum fruit of a plant known as Momordica charantia L. (bitter gourd), has been shown to …

Read the rest of this entry »

Comments

Anti-Diabetic Properties and Phytochemistry Momordica charantia L. (Cucurbitaceae)

1996 Phytomedicine Vol. 2, pp 349-362

by A. Raman, C. Lau
Contents Introduction. Habitat and traditional uses. Studies in human subjects. In vivo studies in laboratory animals. Effects on tissue and enzymes; possible mode of action. Phytochemicals …

Read the rest of this entry »

Comments

Bitter melon (Momordica charantia): A Review of Efficacy and Safety

2003 Archives of Biochemistry and Biophysics VOL 396, PP.207-212

by Ethan Basch, Steven Gabardi and Catherine Ulbricht
Bitter melon (Momordica charantia) is used primarily as an alternative therapy for diabetes. A member of the Cucurbitaceae family, …

Read the rest of this entry »

Comments (1)

Bitter Melon (Momordica charantia): A Review of Efficacy and Safety

February 15, 2003 Am J Health-Syst Pharm. Vol. 60, February 15, 2003

by Ethan Basch, Steven Gabardi and Catherine Ulbricht Bitter melon (Momordica charantia) is used primarily as an alternative therapy for diabetes. A member of the Cucurbitaceae family, …

Read the rest of this entry »

Comments